Pacific Biosciences Of California (PACB) Non-Current Debt (2010 - 2022)

Pacific Biosciences Of California's Non-Current Debt history runs 12 years deep, the most recent figure standing at $500000.0 for Q4 2022.

• In Q4 2022, Non-Current Debt fell 78.26% year-over-year to $500000.0; the TTM figure through Dec 2022 stood at $500000.0 (down 78.26% YoY), while the FY2022 annual figure was $500000.0, down 78.26% from the prior year.
• Non-Current Debt was $500000.0 for Q4 2022 at Pacific Biosciences Of California, down from $2.3 million in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $15.8 million in Q4 2019 to a low of $500000.0 in Q4 2022.
• Historically, Non-Current Debt has averaged $10.8 million across 4 years, with a median of $14.1 million in 2018.
• The sharpest annual moves came in 2018 and 2022: Non-Current Debt jumped 37.57% in 2018, then plunged 78.26% in 2022.
• A 4-year view of Non-Current Debt shows it stood at $14.7 million in 2018, then grew by 7.78% to $15.8 million in 2019, then sank by 85.44% to $2.3 million in 2021, then slumped by 78.26% to $500000.0 in 2022.
• The last three Non-Current Debt figures came in at $500000.0 (Q4 2022), $2.3 million (Q4 2021), and $15.8 million (Q4 2019), per Business Quant data.